Shriram Finance
ICICI Direct
Broker Research reports
for all stocks
- This broker has downgraded this stock from it's previous report. (eg. - Buy->Hold)
- Broker has maintained previous recommendation but reduced share price target.
- This broker has upgraded this stock from it's previous report.(eg. - Sell->Hold)
- Broker has maintained previous recommendation but increased share price target.
RESEARCH REPORTS ALERTS
Load latest
Google or static link led you to an intermediate page.
- All Recent
- Upside
- Buy
- Sell
- Recent Upgrades
- Recent Downgrades
- IPO
- Sector Updates
- Most Recent
- Top Upside
Click on any table column to sort reports by date, stock name, broker, price, target, upside or recommendation.
| Summary | Date | Stock | Author | LTP | Target | Price at reco (Change since reco%) |
Upside(%) | Type | Report | Discuss | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 28 Oct 2024 | Shriram Finance |
ICICI Direct
|
623.25 | 3600.00 | 3259.30 (-80.88%) | Pre-Bonus/ Split |
Buy
|
||||
| 28 Oct 2024 | Nifty 50 |
SBI Securities
|
25330.25 |
Strategy Note
|
|||||||
| 27 Oct 2024 | Bandhan Bank |
Emkay
|
164.28 | 175.00 | 168.21 (-2.34%) | Target met |
Sell
|
Logs a better 2Q than peers, but rising MFI stress still concerning
Emkay
Bandhan Bank reported a 6% PAT beat at Rs9.4bn and RoA of 2.1%, mainly led by higher other income and lower than expected provisions – better than some peers that posted sharp earning downgrades.
|
|||
| 27 Oct 2024 | Poonawalla Fincorp |
Emkay
|
447.10 | 240.00 | 297.05 (50.51%) | 46.32 |
Sell
|
Disappointing Q2 on clean-up act; execution remains key for the ambitious plan
Emkay
Poonawalla Fincorp reported disappointing Q2 numbers with the credit cost of Rs9.1bn (including Rs6.7bn one-time provisioning on the STPL book) leading to the company posting a Rs4.7bn loss.
|
|||
| 27 Oct 2024 | Bank of Baroda |
Emkay
|
245.89 | 325.00 | 239.52 (2.66%) | 32.17 |
Buy
|
Better growth and asset quality performance
Emkay
Bank of Baroda (BoB) reported strong PAT beat at Rs52bn/RoA of 1.3%, mainly due to higher other income (led by treasury gains and recovery in TWO accounts), and partly offset by higher provisions (including contingent provisions).
|
|||
| 27 Oct 2024 | Atul |
Motilal Oswal
|
6543.00 | 9995.00 | 7404.55 (-11.64%) | 52.76 |
Buy
|
Impressive show continues in both the business segments
Motilal Oswal
Atul (ATLP) reported in-line revenue in 2QFY25. Revenue in the Life Science Chemicals segment increased 13% YoY, while it rose 18% YoY in the Performance & Other Chemicals segment.
|
|||
| 27 Oct 2024 | Birla Corporation |
Anand Rathi
|
1291.80 | 1689.00 | 1120.05 (15.33%) | 30.75 |
Buy
|
Near-term pain to persist; maintaining a Buy
Anand Rathi
Weak demand because of the prolonged monsoon, less government infra funding and keen competition hurt Birla Corp’s Q2. Its FY25 volume guidance was lowered to 3-4% as demand at its core regions would be curbed by Mahakumbh (Central) and elections (Maharashtra) where EBITDA/tonne has been guided to rise Rs150-170 in H2 FY25.
|
|||
| 27 Oct 2024 | InterGlobe Aviation |
Motilal Oswal
|
5746.50 | 4130.00 | 4366.10 (31.62%) | Target met |
Neutral
|
||||
| 27 Oct 2024 | Indian Energy Exchange |
Motilal Oswal
|
148.44 | 200.00 | 180.76 (-17.88%) | Target met |
Neutral
|
Revenue in line; volumes remain robust
Motilal Oswal
IEX delivered standalone revenue of INR1,392m in 2QFY25 (+28% YoY), in line with our estimate. Reported standalone PAT of INR1,061m came in 3% above our est. of INR1,025m (+28% YoY), mainly led by higher other income.
|
|||
| 27 Oct 2024 | IDFC First Bank |
Motilal Oswal
|
71.84 | 73.00 | 65.50 (9.68%) | Target met |
Neutral
|
||||
|
more
loading
|
|||||||||||
* Please note that subscribers can download a maximum of 300 reports a month and 70 reports everyday.